Aurinia Pharmaceuticals to Present at the 2016 Rodman & Renshaw 18th Annual Global Investment Conference
September 07 2016 - 7:00AM
Business Wire
Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX:AUP) today
announced that its Chief Operating Officer, Michael R. Martin, will
present a corporate overview of the Company at the 2016 Rodman
& Renshaw 18th Annual Global Investment Conference, taking
place September 11th-13th at the Lotte New York Palace Hotel in New
York City. The presentation will also be available via webcast at
the link listed below.
Aurinia Presentation
Details
Date:
Monday, September 12th, 2016
Time:
10:00 a.m. Eastern time
Location:
Lotte New York Palace Hotel, Louis Room
(4th floor)
Webcast:
http://wsw.com/webcast/rrshq26/auph
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The company
is headquartered in Victoria, BC and focuses its development
efforts globally.
Visit www.auriniapharma.com for more information.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160907005670/en/
Investor & Media Contact:Celia EconomidesAssociate
VP, Investor Relationsceconomides@auriniapharma.com